ORAMED PHARMACEUTICALS INC. Other Liabilities
ORAMED PHARMACEUTICALS INC. (ORMP) had Other Liabilities of $63.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:OtherLiabilities · last filed 2024-05-09
- 2024-03-31: Other Liabilities $63.00K.
- 2023-12-31: Other Liabilities $63.00K.
- 2023-09-30: Other Liabilities $61.00K.
- 2023-06-30: Other Liabilities $66.00K.
| Period end | Other Liabilities |
|---|---|
| 2024-03-31 | $63.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $63.00K 10-Q · filed 2024-05-09 |
| 2023-09-30 | $61.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $66.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $59.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $61.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $61.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $60.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $99.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $99.00K 10-K · filed 2023-03-06 |
| 2021-11-30 | $122.00K 10-Q · filed 2022-01-11 |
| 2021-08-31 | $124.00K 10-QT · filed 2022-03-30 |
| 2020-08-31 | $211.00K 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |